Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor as adjunctive therapy in hyperphosphatemia (AMPLIFY)
NCT03824587Phase 3Completed
- Sponsor
- Ardelyx
- Start
- Feb 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in hyperphosphatemia, sponsored by Ardelyx. Started Feb 2019; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT03824587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824587.